Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylnaltrexone in adults with advanced illness and opioid-induced constipation
NCT00672477Phase 4Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Jun 2008
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 4 trial of methylnaltrexone in opioid-induced constipation (OIC), sponsored by Valeant Pharmaceuticals. Started Jun 2008; status: completed.
02
Drugs
methylnaltrexone
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT00672477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00672477.